BR112021004880A2 - composições farmacêuticas adequadas para entrega articular e uso das mesmas no tratamento de dor nas articulações - Google Patents

composições farmacêuticas adequadas para entrega articular e uso das mesmas no tratamento de dor nas articulações Download PDF

Info

Publication number
BR112021004880A2
BR112021004880A2 BR112021004880-4A BR112021004880A BR112021004880A2 BR 112021004880 A2 BR112021004880 A2 BR 112021004880A2 BR 112021004880 A BR112021004880 A BR 112021004880A BR 112021004880 A2 BR112021004880 A2 BR 112021004880A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
fact
μmoles
phospholipids
joint
Prior art date
Application number
BR112021004880-4A
Other languages
English (en)
Portuguese (pt)
Inventor
Yun-Long Seng
Sheue-Fang Shih
Po-Chun Chang
Lo CHANG
Original Assignee
Tlc Biopharmaceuticals, Inc.
Taiwan Liposome Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tlc Biopharmaceuticals, Inc., Taiwan Liposome Co., Ltd. filed Critical Tlc Biopharmaceuticals, Inc.
Publication of BR112021004880A2 publication Critical patent/BR112021004880A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112021004880-4A 2018-09-16 2019-09-16 composições farmacêuticas adequadas para entrega articular e uso das mesmas no tratamento de dor nas articulações BR112021004880A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862731941P 2018-09-16 2018-09-16
US62/731,941 2018-09-16
PCT/US2019/051247 WO2020056399A1 (en) 2018-09-16 2019-09-16 Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain

Publications (1)

Publication Number Publication Date
BR112021004880A2 true BR112021004880A2 (pt) 2021-06-01

Family

ID=68084954

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021004880-4A BR112021004880A2 (pt) 2018-09-16 2019-09-16 composições farmacêuticas adequadas para entrega articular e uso das mesmas no tratamento de dor nas articulações

Country Status (15)

Country Link
US (1) US12208104B2 (https=)
EP (1) EP3849522A1 (https=)
JP (1) JP7634476B2 (https=)
KR (1) KR20210060559A (https=)
CN (1) CN112702993A (https=)
AU (1) AU2019339528B2 (https=)
BR (1) BR112021004880A2 (https=)
CA (1) CA3112234A1 (https=)
CL (1) CL2021000627A1 (https=)
IL (1) IL281513A (https=)
MX (1) MX2021003030A (https=)
SG (1) SG11202102400PA (https=)
TW (1) TWI843751B (https=)
WO (1) WO2020056399A1 (https=)
ZA (1) ZA202101688B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3187955A1 (en) 2020-08-05 2022-02-10 Sheue-Fang Shih Pharmaceutical composition of intra-articular corticosteroid for pain control
WO2024230404A1 (zh) * 2023-05-05 2024-11-14 中南大学湘雅医院 一种治疗关节疼痛的氢氧化镁纳米粒、其制备方法及应用
TW202519194A (zh) * 2023-11-03 2025-05-16 台灣微脂體股份有限公司 用於疼痛控制之關節內皮質類固醇的微脂體組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050152962A1 (en) * 2002-06-12 2005-07-14 Metselaar Josbert M. Composition for treatment of inflammatory disorders
EP1371362A1 (en) * 2002-06-12 2003-12-17 Universiteit Utrecht Holding B.V. Composition for treatment of inflammatory disorders
DK2797601T3 (en) 2012-02-10 2018-06-14 Taiwan Liposome Co Ltd PHARMACEUTICAL COMPOSITIONS FOR REDUCING COMPLICATIONS BY Ocular steroid
RU2677658C2 (ru) * 2012-07-05 2019-01-18 Тайвэн Липосом Ко, Лтд. Способы лечения артрита

Also Published As

Publication number Publication date
TWI843751B (zh) 2024-06-01
JP7634476B2 (ja) 2025-02-21
US20210338688A1 (en) 2021-11-04
CL2021000627A1 (es) 2021-09-10
IL281513A (en) 2021-04-29
SG11202102400PA (en) 2021-04-29
CN112702993A (zh) 2021-04-23
WO2020056399A1 (en) 2020-03-19
US12208104B2 (en) 2025-01-28
JP2022500364A (ja) 2022-01-04
TW202023569A (zh) 2020-07-01
ZA202101688B (en) 2024-06-26
MX2021003030A (es) 2021-05-27
AU2019339528A1 (en) 2021-04-15
AU2019339528B2 (en) 2025-01-30
CA3112234A1 (en) 2020-03-19
KR20210060559A (ko) 2021-05-26
EP3849522A1 (en) 2021-07-21

Similar Documents

Publication Publication Date Title
JP6964571B2 (ja) 関節炎の処置方法
BR112021004880A2 (pt) composições farmacêuticas adequadas para entrega articular e uso das mesmas no tratamento de dor nas articulações
EP3820479B1 (en) Methods to reduce complications of intra-articular steroid
RU2810788C2 (ru) Фармацевтические композиции, подходящие для суставной доставки, и их применение при лечении суставной боли
RU2806023C2 (ru) Способы уменьшения осложнений от внутрисуставного стероида
US12514820B2 (en) Pharmaceutical composition of intra-articular corticosteroid for pain control
HK40041739A (en) Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain
HK40087158A (zh) 用於疼痛控制的关节内皮质类固醇的药物组合物
HK40041258A (en) Methods to reduce complications of intra-articular steroid

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]